Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products.
52W Range
8thpctl
Volume
0.52×avg
Market Cap
6.73MUSD
P/E Ratio
-0.3TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Citius Pharmaceuticals, Inc.
CTXRNASDAQ Capital Market·USD·Closed
Citius Pharmaceuticals, Inc.
CTXRNASDAQ·USD·Closed
$0.60
−4.28%
$0.60
−$0.03 (4.28%)
52W Range
8thpctl
Volume
0.52×avg
Mkt Cap
6.73MUSD
P/E
-0.3TTM
Div Yield
–ann
CTXR: Citius Pharmaceuticals, Inc. Stock Analysis | finqOS
